Economic and Policy Analysis of University-based Drug ???Detailing???

Soumerai, Stephen B.; Avorn, Jerry

doi:10.1097/00005650-198604000-00003

Cited by 144 publications

(117 citation statements)

References 14 publications

Supporting

Mentioning

113

Contrasting

Unclassified

Order By: Relevance

“…40,41 Evidence indicates that academic detailing may provide benefits that exceed the costs for some but not all interventions. [42][43][44][45][46][47][48] Academic detailing has become a cornerstone of interventions to optimize prescribing in 3 provinces that have fully funded programs providing services to all practising family physicians. Although smaller academic detailing programs exist, more support is required to maintain the key principles of academic detailing throughout Canada.…”

Section: Role Of the Pharmacistmentioning

confidence: 99%

A Brief Overview of Academic Detailing in Canada: Another Role for Pharmacists

Jin¹,

Naumann²,

Regier³

et al. 2012

Can Pharm J

View full text Add to dashboard Cite

Section: Role Of the Pharmacistmentioning

confidence: 99%

A Brief Overview of Academic Detailing in Canada: Another Role for Pharmacists

Jin¹,

Naumann²,

Regier³

et al. 2012

Can Pharm J

View full text Add to dashboard Cite

“…[1][2][3] Controversy surrounds the use of free samples. 4 Studies have described potential safety problems, 5,6 health professionals who divert samples for self-administration or resale, [7][8][9][10] the influence of pharmaceutical representatives who distribute samples, [11][12][13] and the contribution of samples to rising drug and health insurance costs. [14][15][16] In addition, numerous studies suggest that free samples may influence the prescribing behavior of physicians and trainees.…”

mentioning

confidence: 99%

Characteristics of Recipients of Free Prescription Drug Samples: A Nationally Representative Analysis

et al. 2008

View full text Add to dashboard Cite

at least 1 free sample. A higher proportion of persons who had continuous health insurance received a free sample (12.9%) than did persons who were uninsured for part or all of the year (9.9%; P < .001). The poorest third of respondents were less likely to receive free samples than were those with incomes at 400% of the federal poverty level or more. After we controlled for demographic factors, we found that neither insurance status nor income were predictors of the receipt of drug samples. Persons who were uninsured all or part of the year were no more likely to receive free samples (odds ratio [OR]=0.98; 95% confidence interval [CI]=0.087, 1.11) than were those continuously insured.Conclusions. Poor and uninsured Americans are less likely than are wealthy or insured Americans to receive free drug samples. (Am J Public Health. 2008;98: XXX-XXX.

show abstract

“…Based on this behavioral science and several field trials, it is possible to define the theory and practice of methods to improve physicians' clinical decision making to enhance the quality and cost-effectiveness of care. Some of the most important techniques of such "academic detailing" include (1) conducting interviews to investigate baseline knowledge and motivations for current prescribing patterns, (2) focusing programs on specific categories of physicians as well as on their opinion leaders, (3) defining clear educational and behavioral objectives, (4) establishing credibility through a respected organizational identity, referencing authoritative and unbiased sources of information, and presenting both sides of controversial issues, (5) stimulating active physician participation in educational interactions, (6) using concise graphic educational materials, (7) highlighting and repeating the essential messages, and (8) …”

mentioning

confidence: 99%